Home
Search
GO
FDA-Approved Subcutaneous Immunotherapy Option Available for Eligible Patients With Certain Cancers
Medical Oncologist, Dr. Saby George and Audrey Davis, VP Program & Health Equity, Cancer Support Community, discuss an FDA-approved immunotherapy-based treatment option. Sponsored by Bristol Myers Squibb.